youtube_live
Q2 2027 earnings • released • EPS beat +20,18% • Revenue beat +9,66%
See resultschevron_right
GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
2 521,60 ₹
arrow_downward
-0,40%(-10,20) 1D
5 նոյ, 10:41:21 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
2 549,80 ₹
High
2 573,40 ₹
Low
2 511,50 ₹
Mkt. cap
427,17 մլրդ
Avg. vol.
69,12 հզր
Volume
32,40 հզր
Dividend
2,26%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,99
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
Open
2 549,80 ₹
High
2 573,40 ₹
Low
2 511,50 ₹
Mkt. cap
427,17 մլրդ
Avg. vol.
69,12 հզր
Volume
32,40 հզր
Dividend
2,26%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,99
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
ABC News - Breaking News, Latest News and Videos
·
46 րոպե առաջ
Asian shares mostly advance following US midterms, though Kospi falls on selling of chipmakers
WXXV News 25
·
1 ժամ առաջ
Stocks surge, and the Dow soars 1,500 points as oil prices tumble following the US midterm elections
Moomoo
·
1 ժամ առաջ
Truths about Datacenters Built-out in Blue States
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd